SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
VRNO

Verano Holdings Corp. (OTC:VRNO)

US · Delayed Price · Currency is USD
Also listed: VRNO.NEHealthcare · Drug Manufacturers - Specialty & Generic
$3.17-$0.30 (-8.70%)
 
Market cap
$231M
Insider Score
Health Score
Listed since
Feb 17, 2021
Website
Market Cap$231.20M-30.8%
Revenue (ttm)$853.36M+2.7%
Net Income-$206.41M+40.5%
EPS-$3.02+37.4%
Shares Out72.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume88,801
Open$3.40
Previous Close$3.47
Day's Range$3.17 - $3.58
52-Week Range$3.03 - $9.75
Beta1.42
Analystsn/a
Price Targetn/a
Earnings DateMar 11, 2027

About VRNO

Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. The company also designs, builds, and operates cannabis dispensaries. It sells its products under the Encore, Avexia, MÜV, Savvy, Essence, BITS, HYPHEN, Swift Lifts, Verano, and Zen Leaf brand names to medical and adult use markets. The company is headquartered in Chicago, Illinois.

Address
224 West Hill Street, Chicago, IL, 60610, US
Market Cap
231 million
Employees
3,800
Industrial Classification
Drug Manufacturers - Specialty & Generic

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$65.17K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From VRNO’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-8.70%
5 Days
-22.11%
1 Month
-39.96%
6 Months
-41.83%
1 Year
-30.79%

$VRNO stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in VRNO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by VRNO's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

VRNO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

VRNO Revenue by Segment

$516.04MTotal
Revenues, net of Discounts$212.44M41.17%
Retail$179.32M34.75%
Wholesale$73.92M14.32%
Adjusted EBITDA$50.35M9.76%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New VRNO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to VRNO from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in VRNO

MSOSAdvisorShares Pure US Cannabis ETF$27.13M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from VRNO’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
5
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

MSOSAdvisorShares Pure US Cannabis ETF3.22%
IFRF.TOIA Clarington Loomis Floating Rate Income Fund0.06%

Weight is the stock’s share of each fund’s holdings.